Govorestat (AT-007) demonstrates consistent and sustained clinical benefit in children with galactosemia across symptoms of greatest concern to patients and caregivers ALBANY, N.Y., April 26, 2023 /PRNewswire/ — The Galactosemia Foundation, a non-profit charitable organization that…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.